We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Kintor Pharmaceutical Limited announced that it has received approval from the National Medical Products Administration to begin clinical trials for GT20029 (tincture/gel) for the treatment of acne and androgenetic alopecia.